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Discrepancies in published results about the role of N-cadherin in hematopoietic stem cells have led to confu-
sion in the field. Attempting to settle the disagreements and reach a consensus, we undertook a collective
discussion approach. This process clarified a number of issues but left some questions still unresolved.Background
One of the fundamental principles in
biology is that cells in multicellular organ-
isms interact and communicate with
surrounding cells to acquire or maintain
certain properties. This principle is rele-
vant for stem cell biologists as they
examine the ‘‘niche’’ hypothesis. The
‘‘stem cell niche’’ concept was first
applied to the mammalian hematopoietic
stem cell (HSC) field in 1978 (for a review
of this area, see Voog and Jones, 2010);
however, because of the rarity and low
accessibility of HSCs, as well as the lack
of specific HSC markers, it has been diffi-
cult to examine the specific contact of
HSCs with niche cells.
Drosophila researchers adopted the
niche concept and demonstrated that
DE-cadherin and b-catenin interact at
the interface between germline stem
cells (GSCs) and niche cells. Loss of DE-
cadherin leads to the loss of GSCs.
These observations in Drosophila gonads
encouraged the mammalian HSC field
to examine the role of cadherin in the
marrow niche.
Bone marrow contains a variety of cells
that make up stem cell niche. There is
evidence suggesting that some cells in
the bone marrow express N-cadherin.
Three papers published in 2003 and 2004
proposed that bone marrow osteoblasts
are HSC niche cells, and two of them
additionally showed that osteoblasts and
HSCs are positive for immunohistochem-
ical staining with a polyclonal anti-N-cad-
herin antibody (YS, Japan) (Calvi et al.,
2003; Zhang et al., 2003; Arai et al.,
2004). However, none of the studies
identified a functional role for N-cadherin
in the HSC niche. Wilson et al. (2004) found
that KLS (c-kit+lineageSca-1+) cells are amixture of N-cadherin-positive and -nega-
tive cells based on staining with the YS
antibody, but whether those YS anti-
body-positive cells were long-term repo-
pulating HSCs was unclear. In their model,
HSCs lacking c-myc maintain a high level
of N-cadherin and other adhesion mole-
cules to enhance stem cell-niche interac-
tion and therefore promote HSC expan-
sion, whereas HSCs with high c-myc
repress the adhesion molecules, causing
the loss of stem cell-niche interaction
and progressive exhaustion of stem cell
pool. Later, Hosakawa et al. demonstrated
that reactive oxygen species downregu-
lated expression of N-cadherin in LSK-SP
(c-kit+lineageSca-1+-side population)
cells by quantitative RT-PCR and
proposed a role of N-cadherin in the
HSC-niche interaction (Hosokawa et al.,
2007). Another follow-up study detected
N-cadherin expression in Flk2LSK HSCs
by flow cytometry with a monoclonal N-
cadherin antibody (MNCD2) that was veri-
fied by RT-PCR. This study indicated that
the YS polyclonal antibody does not reli-
ably indicate N-cadherin and instead
concluded that flow cytometry with
MNCD2 can be used to identify distinct
subpopulations of HSCs (Haug et al.,
2008). The authors concluded that
Flk2LSK cells that express intermediate
levels of N-cadherin (N-cadherinint) are
quiescent HSCsthat lacksignificant recon-
stituting potential upon transplantation into
irradiated mice, whereas cells expressing
low levels of N-cadherin (N-cadherinlo) are
primed/active HSCs with the capacity to
reconstitute irradiated mice (Haug et al.,
2008). However, two other papers reported
no evidence of N-cadherin expression in
Flk2LSK cells or a further enriched popu-
lation, SLAM-LSK HSCs, by a variety ofCell Stem Cetechniques, including antibody staining
and RT-PCR (Kiel et al., 2009; Kiel et al.,
2007). In addition, these authors found
that N-cadherin conditional knockout
mice had no observable phenotype in
HSC frequency, hematopoiesis, long-
term competitive repopulation, or serial
transplantation (Kiel et al., 2009). The
observations from the different groups
were therefore at odds with one another.
A Collaborative Discussion Process
The discrepancies described above were
generating confusion in the published
literature and thus in the field. With the
aim of resolving the controversy and
providing clarification of the issues
involved, we embarked on an interactive
discussion approach. At our (L.I.Z.)
request, the principal investigators from
the two groups that have generated the
majority of the conflicting published
data, Linheng Li and Sean Morrison,
participated in a telephone conference in
which each investigator presented and
discussed pertinent data slides. This
meeting also included another investi-
gator, Toshio Suda, who has published
work suggesting a positive role for N-cad-
herin in the bone marrow, and the editor of
Cell Stem Cell, Deborah Sweet. This joint
discussion was followed by a series of
one-on-one phone meetings and two
other telephone conferences with L.I.Z.
During the discussion, it became clear
that the disagreement centered on three
major questions: (1) Do HSCs express
N-cadherin? (2) Is the MNCD2 mono-
clonal antibody specific for N-cadherin?
(3) Does N-cadherin play a role in HSC
maintenance and regulation? Involving
the groups who had previously come to
differing conclusions in a joint discussionll 6, March 5, 2010 ª2010 Elsevier Inc. 199
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ical analysis of key experimental data
and honest expression of opinion about
the relevant issues.
With the available information, some
conclusions about the first two issues
became clear, and these will be outlined
below. However, we were not able to
reach an agreement on the third question
on the basis of the available data. Upon
the senior scientist’s suggestion, the Li
and Morrison labs agreed to indepen-
dently perform a limiting dilution compet-
itive transplantation with the exact same
experimental conditions and N-cadherin
conditional knockout mice, with a view
to comparing data and coming to a
consensus conclusion. Several emails
between the groups outlined in detail
the methods, doses of cells, and mecha-
nism of conditional inactivation of N-cad-
herin. Six months later, we set up a phone
call to examine the data from the two
laboratories.
Agreements and Outstanding
Issues
During our initial discussions, we were
able to come to agreement on a number
of points relating to detection of N-cad-
herin expression in bone marrow cells.
In previous studies, the expression of
N-cadherin in HSCs has been examined
at the mRNA level. The Li and Suda
groups found that N-cadherin mRNA
can be detected in highly enriched popu-
lations of stem cells by quantitative
RT-PCR (Haug et al., 2008; Hosokawa
et al., 2007; Hosokawa et al., 2010), but
Morrison and colleagues did not detect
any expression by qRT-PCR or by micro-
array analysis (Kiel et al., 2007). Indeed,
even in the Li and Suda groups’ qRT-
PCR assays, the expression level in
HSCs was found to be very low compared
with some non-HSC control populations.
Moreover, no microarray analysis by any
group has ever reported the enrichment
of N-cadherin in HSCs. With very low
levels of expression, divergent findings
could potentially be explained by differ-
ences in experimental methods and assay
sensitivities. The overall conclusion from
these data is that N-cadherin RNA is
either present at very low levels or absent
in HSCs.
The majority of the protein expression
data presented by Haug et al. were
obtained using a monoclonal antibody200 Cell Stem Cell 6, March 5, 2010 ª2010 Eagainst N-cadherin, MNCD2 (Haug et al.,
2008). Therefore, challenges to the con-
clusion that HSCs might express varying
low levels of N-cadherin on their sur-
face have centered on concerns about
the specificity of the MNCD2 reagent.
MNCD2 was originally developed by
Matsunami and Takeichi in 1995 (Matsu-
nami and Takeichi, 1995), and its speci-
ficity for N-cadherin in western blots
was demonstrated by Radice et al., who
compared wild-type and N-cadherin null
mice (Radice et al., 1997). The Morrison
and Li groups also independently con-
firmed that MNCD2 was specific for
N-cadherin by western blotting and
immunostaining using neonatal forebrain
cells and cell lines in which N-cadherin is
abundantly expressed (Kiel et al., 2009;
Haug et al., 2008). To examine whether
N-cadherin is expressed in enriched
HSCs, Kiel et al. sorted 105 LSK cells
and carried out western blot analysis
with MNCD2. They failed to detect any
N-cadherin protein despite readily detect-
ing N-cadhrerin in a few thousand fore-
brain cells (Kiel et al., 2009). Thus, the
available data suggest that MNCD2
does give a specific signal by Western
blot in tissues in which N-cadherin is
highly expressed, but Western blotting
with MNCD2 has not been able to con-
firm N-cadherin expression in the LSK
cells. These observations provide further
support for the idea that N-cadherin is
expressed in a very limited hematopoetic
cell population and/or at extremely low
levels, or may in fact be absent. Using
improved Western blotting techniques
and a large number of highly purified cells
might reveal the answer.
The above conclusions about the
expression level of N-cadherin in HSCs
raise the possibility that signals obtained
for MNCD2 with other assays could be
the result of nonspecific binding. Use of
the MNCD2 antibody for flow cytometry
with enriched HSCs has proved problem-
atic. Haug et al. did see a shift in MNCD2
staining with Flk2-LSK cells compared
with the control omitting MNCD2, but
in their published study they did not
compare this staining with isotype con-
trols to assess staining above back-
ground or non-specific antibody binding
(Haug et al., 2008). Kiel et al. (2007,
2009) were unable to detect any staining
of SLAM-LSK or Flk2-LSK HSCs using
MNCD2 or other commercially availablelsevier Inc.anti-N-cadherin antibodies. Moreover,
both Kiel et al. and Foudi et al. found
that MNCD2 strongly stained surface
B220+ B cells in the bone marrow, but
when these cells were sorted and
analyzed by Western blot, no N-cadherin
band was evident (Foudi et al., 2009;
Kiel et al., 2009). The Morrison and Hock
groups also examined HSCs enriched by
multiple combinations of markers, such
as SLAM-LSK and Flk2-LSK, and neither
group observed any effect of N-cadherin
deficiency on the MNCD2 staining of
HSCs or other bone marrow cells (Foudi
et al., 2009; Kiel et al., 2009). To some
extent the differences in results could be
due to variation in flow cytometry tech-
nique between the labs, different sub-
clones of hybridoma used to produce
the antibody, or the conditional knockout
efficiency. However, the Morrison labora-
tory tested multiple aliquots of MNCD2
antibody obtained from the Li laboratory
as well as directly from the Developmental
Studies Hybridoma Bank and confirmed
in all of their experiments that N-cadherin
deletion was complete or nearly complete
by PCR (S.M. unpublished data). Con-
cerns about these technical differences
are heightened by the very low level of
proposed N-cadherin expression and
the non-specific binding of MNCD2 to
HSCs/progenitors. There is no indication
from any group that HSCs express high
levels of N-cadherin, and instead the
accumulated data are consistent with
a low level of expression, if any at all,
that might be limited to a very small
subset of HSCs. Although very low levels
of proteins can have a function in cell
biology, these data currently cannot be
used to support an important HSC func-
tion of N-cadherin. These conclusions
formed the backdrop against which we
discussed our viewpoints on functional
studies.
To address the question of whether
N-cadherin is required for HSC mainte-
nance, Kiel et al. (2009) studied N-cad-
herin conditional knockout mice, as the
germline knockout is embryonic lethal.
They did not observe any change of HSCs
or hematopoiesis in homeostatic situa-
tions up to 5 months after N-cadherin
deletion (using Mx-1-Cre). To further chal-
lenge the HSCs, they transplanted 106
bone marrow cells from the N-cadherin
conditional knockout mice with com-
parable numbers of competitive bone
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icant difference in chimerism relative to
wild-type donor cells, even in secondary
transplantation. From these experiments,
they concluded that HSCs ‘‘do not depend
on N-cadherin to regulate their mainte-
nance.’’ N-cadherin could potentially still
be required during regeneration or the
response to certain types of stresses,
and testing the N-cadherin knockout
animals for their response during various
stresses or irradiation could be inter-
esting. However, the Morrison group
failed to see any effect of N-cadherin dele-
tion on the recovery of mice in response
to 5-fluorouracil treatment (Kiel et al.,
2009), indicating that N-cadherin does
not play an important role in at least this
stress condition.
During the discussion, the transplanta-
tion data by Kiel et al. (2009) were ques-
tioned. One potential issue related to the
knockout efficiency in the donor mice,
and it was suggested that using reporter
mice that can indicate the Cre-mediated
recombination activity could be helpful.
However, with such an approach it is still
possible that the recombination efficiency
at the reporter locus could be different
from the N-cadherin locus, or could vary
between cell populations. As an alterna-
tive approach, Morrison’s group purified
the LT-HSC for clonal culture and per-
formed PCR on each individual colony,
showing the knockout efficiency was
almost 100%. In addition, the donor-
derived cells in the recipients’ peripheral
blood are also N-cad/, further confirm-
ing the knockout efficiency (Kiel et al.,
2009). Based on these results, it seems
unlikely that the failure to observe a
phenotype is due to incomplete knockout.
Even though transplantation is consid-
ered the gold standard for testing stem
cell functionality, the field has not been
able to agree on standardized proce-
dures, and there are substantial inter-lab
variances in aspects of hematopoietic
transplantation protocols such as donor
cell numbers and the cut-off for long-
term multi-lineage reconstitution. In an
attempt to address the controversy in
a rigorous way, L.I.Z. suggested that
both groups perform a limiting dilution
competitive transplantation indepen-
dently and compare results, and they
agreed to do so. The agreed experiment
was that 20,000, 60,000 and 200,000
wild-type or N-cad conditional knockoutwhole bone marrow cells would be trans-
planted together with 200,000 competitor
cells, and the results examined 16 weeks
after transplantation. Six months later,
however, only the Morrison lab presented
data from the agreed experiment
(M. Acar, M. Kiel, and S. Morrison, unpub-
lished data). We examined the resulting
data with a biostatistician using standard
software for calculating the frequency of
hematopoietic stem cell engraftment and
ANOVA analysis, and found that there
was no difference between the wild-type
and N-cadherin deficient groups, consis-
tent with the conclusions published
previously by Kiel et al. (2009). For addi-
tional verification, we also showed the
entire analysis to an independent investi-
gator in the hematopoietic stem cell
field, who also ran the data through statis-
tical software and came to the same
conclusion. Complete N-cadherin dele-
tion was confirmed in these experiments
by PCR of genomic DNA from donor cells
sorted from the reconstituted mice.
However, instead of the agreed set of
experiments the Li lab independently
chose to undertake a different approach
involving using a Cre-loxP reporter
system to indirectly indicate the recombi-
nation/knockout efficiency and trans-
planting purified reporter positive and
reporter negative cells separately. They
observed a difference between these
two subsets of cells, which they inter-
preted as indicating a role for N-cadherin
in HSCs (L. Li, unpublished data).
However, in our view these experiments
are not straightforward to interpret and
are therefore not informative for resolving
the question at hand. Thus, at this point
our conclusion is that no substantial
HSC phenotype associated with N-cad-
herin conditional deletion has been
observed, suggesting that N-cadherin
does not play an essential functional role
in HSCs.
Future Questions
Although the data available at this point
do not indicate an essential role of N-cad-
herin in HSCs, redundancy in cadherin
function in HSCs remains a possibility.
Early experiments showed that HSCs do
not express E-cadherin (Zhang et al.,
2003). However, in this issue of Cell
Stem Cell Toshio Suda’s group show
that the N-cadherin mRNA level in LSK
cells differs between mouse strains byCell Stem CeqRT-PCR (Hosokawa et al., 2010). They
found that the C57BL/6 strain has signifi-
cantly higher N-cadherin level than the
129/Sv strain, from which the N-cadher-
infl/- mice were originally derived (Kostet-
skii et al., 2005). In contrast, the 129/Sv
strain has higher expression of other
cadherins than the C57BL/6 strain. This
could indicate that different cadherins
are used by different strains. Interestingly,
the Suda group found that overexpress-
ing a dominant-negative(DN) N-cadherin
inhibits the lodgment and long-term repo-
pulating activities of HSCs, while overex-
pressing wild-type N-cadherin has the
opposite effect (Hosokawa et al., 2010).
Because of the non-specific blocking of
cadherin family members by the DN-N-
cadherin (Fujimori and Takeichi, 1993),
this result leaves open the possibility
that cell adhesion mediated by the redun-
dant cadherin family members might be
involved in HSC activities.
However, it is worth noting that Kiel
et al. were not able to detect N-cadherin
mRNA in C57BL HSCs and studied
knockout mice that were backcrossed
with C57BL/6 for at least six generations,
arguing against the idea that strain back-
ground is a basis for the discrepancy in
results (Kiel et al., 2009). Thus, although
potential strain differences are intriguing,
currently it does not appear likely they
can provide an explanation for the dif-
ferent conclusions drawn.
In summary, therefore, although there
are still differences of opinion among the
investigators involved in this process
regarding the potential for N-cadherin
function in HSCs, it is our view that to
move the research in the field forward
we need to acknowledge the current
observations and set a common founda-
tion for the stem cell community. The
current observations on the N-cadherin
conditional knockout model indicate that
the maintenance of adult HSCs does not
appear to depend on N-cadherin homo-
philic interactions. This conclusion does
not support or argue against the potential
role of osteoblasts or perivascular cells
in the HSC niche, and it does not entirely
rule out the idea of cadherin-mediated
niche-HSC interaction model as cadherin
redundancy is still a possibility. However,
convincing evidence to support this idea
would require demonstration of a clear
HSC defect in knockout mice, either alone
or in combination with the N-cadherinll 6, March 5, 2010 ª2010 Elsevier Inc. 201
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tive repopulation studies in the mouse.
Our conclusion is that until clear cut data
along these lines are forthcoming, the
field should not base further experiments
on the concept that there is a functionally
significant cell-autonomous role for N-
cadherin in HSCs.
Bullet Point Summary
d N-cadherin expression in HSCs
is either low or undetectable; if
N-cadherin is expressed in HSCs
it is present at a very low level
and/or in a small subset of cells.
d The N-cadherin monoclonal anti-
body, MNCD2, is not specific
for N-cadherin expression in the
hematopoietic compartment. This
antibody should not be used for
experiments that require flow-cyto-
metric sorting of HSCs, although it
still can be used to detect N-cad-
herin expression by Western blot
or immunostaining in tissues that
express high levels of N-cadherin,
such as liver.202 Cell Stem Cell 6, March 5, 2010 ª2010 Elsevd Currently available data lead to the
conclusion that the maintenance
of adult HSCs does not depend on
a cell-autonomous role of N-cad-
herin. To argue against this conclu-
sion, future experiments would
need to demonstrate that genetic
deficiency of another component,
such as a different cadherin,
causes a substantial HSC pheno-
type in N-cadherin conditional
knockout mice.REFERENCES
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